Sugi Predict

Sugi Predict / Compounds / SCHEMBL4652134

SCHEMBL4652134

SCHEMBL4652134

CCOC(=O)C(NC(=O)c1ccc(Cl)cc1)C(=O)OCC

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.60
▸ EPHX2 P34913 1/20 0.53
▸ TRPA1 O75762 1/20 0.49
▸ KDM4E B2RXH2 4/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ MAPT P10636 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ GAA P10253 2/20 0.47
▸ POLB P06746 2/20 0.46
▸ CTDSP1 Q9GZU7 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ HDAC3 O15379 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ CNR2 P34972 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5782189 0.87 KMT2A (0.54) SMN1; SMN2ALDH1A1MAPTLMNAL3MBTL1
SCHEMBL9464645 0.86 HTT (0.59) HTTSMN1; SMN2EPHX2TRPA1KDM4E
SCHEMBL9464650 0.86 HTT (0.59) HTTSMN1; SMN2EPHX2TRPA1KDM4E
SCHEMBL17010276 0.85 ESR1 (0.56) HTTSMN1; SMN2ALDH1A1MAPTLMNA
SCHEMBL3365792 0.85 HTT (0.57) HTTSMN1; SMN2TRPA1KDM4EALDH1A1
SCHEMBL14786715 0.84 TAS1R3 (0.43) HTTSMN1; SMN2MAPTLMNAGAA
SCHEMBL655688 0.84 ALDH1A1 (0.56) SMN1; SMN2EPHX2KDM4EALDH1A1MAPT
SCHEMBL5784044 0.83 SMN1; SMN2 (0.55) SMN1; SMN2EPHX2ALDH1A1GAARAB9A
SCHEMBL5424180 0.83 TAS1R3 (0.61) SMN1; SMN2EPHX2KDM4EALDH1A1MAPT
SCHEMBL14724516 0.81 RAB9A (0.58) SMN1; SMN2ALDH1A1L3MBTL1GAACTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110426463-B Method for detecting related substances in p-chlorobenzoylamino diethyl malonate sample 苏州正济药业有限公司 2022-03-04 — — CN claimed
CN-110426463-A Detection method in relation to substance in a kind of p-chlorobenzamido diethyl malonate sample SUZHOU TIANMA MEDICINE CO LTD 2019-11-08 — — CN claimed
CN-106632029-A Process for synthesizing rebamipide 大桐制药（中国）有限责任公司 2017-05-10 — — CN claimed
CN-110426463-B Method for detecting related substances in p-chlorobenzoylamino diethyl malonate sample 苏州正济药业有限公司 2022-03-04 — — CN disclosed
CN-110426463-B Method for detecting related substances in p-chlorobenzoylamino diethyl malonate sample 苏州正济药业有限公司 2022-03-04 — — CN disclosed
CN-110426463-B Method for detecting related substances in p-chlorobenzoylamino diethyl malonate sample 苏州正济药业有限公司 2022-03-04 — — CN disclosed
CN-110426463-A Detection method in relation to substance in a kind of p-chlorobenzamido diethyl malonate sample SUZHOU TIANMA MEDICINE CO LTD 2019-11-08 — — CN disclosed
CN-110426463-A Detection method in relation to substance in a kind of p-chlorobenzamido diethyl malonate sample SUZHOU TIANMA MEDICINE CO LTD 2019-11-08 — — CN disclosed
CN-110426463-A Detection method in relation to substance in a kind of p-chlorobenzamido diethyl malonate sample SUZHOU TIANMA MEDICINE CO LTD 2019-11-08 — — CN disclosed
CN-106632029-A Process for synthesizing rebamipide 大桐制药（中国）有限责任公司 2017-05-10 — — CN disclosed
EP-1274686-B1 PROCESS FOR PREPARING 2-(4-CHLOROBENZOLAMINO) -3- 2(1H) -QUINOLINON-4-YL PROPRIONIC ACID KYUNG DONG PHARM CO LTD (KR) 2008-10-01 — — EP disclosed
CN-100361973-C Benzyloxy-substituted tryptophan derivative, its analogs, production and use thereof UNIV FUDAN (CN) 2008-01-16 — — CN disclosed
CN-1817861-A Benzyloxy-substituted tryptophan derivative, its analogs, production and use thereof UNIV FUDAN (CN) 2006-08-16 — — CN disclosed
EP-1274686-A4 PROCESS FOR PREPARING 2-(4-CHLOROBENZOLAMINO) -3- 2(1H) -QUINOLINON-4-YL]PROPRIONIC ACID KYUNG DONG PHARM CO LTD (KR) 2004-09-15 — — EP disclosed
US-6680386-B2 FROM ALKYL 2-(4-CHLOROBENZOYLAMINO)-2-ALKOXYCARBONYL-3-(2(1H)-QUINOLINON-4-YL) PROPIONATE IN THE PRESENCE OF A BASE SOLUTION FOR HYDROLYSIS AND DECARBOXYLATION KYUNG DONG PHARM., CO., LTD. (KR) 2004-01-20 — — US disclosed
US-20030087930-A1 Process for preparing 2-(4-chlorobenzolamino)-3[ (1h)-quinolinon-4-yl] propionic acid LEE BYOUNG-SUK (KR) 2003-05-08 — — US disclosed
EP-1274686-A1 PROCESS FOR PREPARING 2-(4-CHLOROBENZOLAMINO) -3- 2(1H) -QUINOLINON-4-YL]PROPRIONIC ACID Kyung Dong Pharm., CO., LTD (KR) 2003-01-15 — — EP disclosed
WO-2002066436-A1 PROCESS FOR PREPARING 2-(4-CHLOROBENZOLAMINO) -3-[2(1H) -QUINOLINON-4-YL]PROPRIONIC ACID KYUNG DONG PHARM., CO., LTD (KR) 2002-08-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087930-A1 Process for preparing 2-(4-chlorobenzolamino)-3[ (1h)-quinolinon-4-yl] propionic acid SI, PGA5, VIP HTT 4176/4885SMN1; SMN2 4649/4885EPHX2 942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.